DE60234921D1 - Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen - Google Patents

Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Info

Publication number
DE60234921D1
DE60234921D1 DE60234921T DE60234921T DE60234921D1 DE 60234921 D1 DE60234921 D1 DE 60234921D1 DE 60234921 T DE60234921 T DE 60234921T DE 60234921 T DE60234921 T DE 60234921T DE 60234921 D1 DE60234921 D1 DE 60234921D1
Authority
DE
Germany
Prior art keywords
lipid
vessels
administration
hydrophilic molecules
small hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234921T
Other languages
English (en)
Inventor
Robert Heinz Friesen
Berend Poolman
Bernard Lucas Feringa
Jan Bernard Engberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Nanosystems BV
Original Assignee
Applied Nanosystems BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Nanosystems BV filed Critical Applied Nanosystems BV
Application granted granted Critical
Publication of DE60234921D1 publication Critical patent/DE60234921D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60234921T 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen Expired - Lifetime DE60234921D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202401A EP1269993A1 (de) 2001-06-21 2001-06-21 Verabreichung von in Lipidvesikeln verpackten kleinen hydrophilen Molekülen
PCT/NL2002/000412 WO2003000233A2 (en) 2001-06-21 2002-06-21 Delivery of small hydrophilic molecules packaged into lipid vesicles

Publications (1)

Publication Number Publication Date
DE60234921D1 true DE60234921D1 (de) 2010-02-11

Family

ID=8180516

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234921T Expired - Lifetime DE60234921D1 (de) 2001-06-21 2002-06-21 Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen

Country Status (7)

Country Link
US (1) US20030118636A1 (de)
EP (2) EP1269993A1 (de)
AT (1) ATE453380T1 (de)
CA (1) CA2451148A1 (de)
DE (1) DE60234921D1 (de)
DK (1) DK1397123T3 (de)
WO (1) WO2003000233A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3021106B8 (de) 2001-07-30 2019-03-27 Meso Scale Technologies, LLC Verwendung einer prüfelektrode mit immobilisierten lipid-/proteinschichten für lumineszenztestmessungen
WO2003075890A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
ES2831305T3 (es) * 2002-10-29 2021-06-08 Insmed Inc Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares
US7968115B2 (en) 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US7459147B2 (en) 2003-06-30 2008-12-02 L'oreal Cosmetic composition comprising at least one hydrophilic organopolysiloxane, at least one hydrocarbon oil and at least one short hydrocarbon ester
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US20080103213A1 (en) * 2004-03-05 2008-05-01 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of neurofibromatosis
EP3718532A1 (de) 2005-12-08 2020-10-07 Insmed Incorporated Antiinfektive zusammensetzungen auf lipidbasis zur behandlung von lungeninfekten
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US20100189777A1 (en) * 2007-07-20 2010-07-29 Basf Se Functionalized nanocompartments with a transport system
EP2127640A1 (de) 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Modifizierte azid-enthaltende Proteine
WO2010150169A1 (en) 2009-06-24 2010-12-29 Koninklijke Philips Electronics N.V. Method and device for programming a microcontroller
WO2011097480A1 (en) 2010-02-05 2011-08-11 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
EP2852391B1 (de) 2012-05-21 2021-11-17 Insmed Incorporated Systeme zur behandlung von lungenentzündungen
WO2014081300A1 (en) * 2012-11-22 2014-05-30 Tagworks Pharmaceuticals B.V. Channel protein activatable liposomes
RU2018135921A (ru) 2012-11-29 2019-02-05 Инсмед Инкорпорейтед Стабилизированные составы ванкомицина
CN105142614A (zh) * 2013-03-14 2015-12-09 迪克纳制药公司 用于配制阴离子试剂的方法
ES2755941T3 (es) 2014-05-15 2020-04-24 Insmed Inc Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900556A (en) * 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
EP0382736B1 (de) * 1987-07-27 1994-11-02 Commonwealth Scientific And Industrial Research Organisation Rezeptormembranen
US5227470A (en) * 1988-08-26 1993-07-13 Canon Kabushiki Kaisha Method for forming proteoliposome and method for forming giant proteoliposome
WO1990008783A1 (en) * 1989-01-27 1990-08-09 Australian Membrane And Biotechnology Research Institute Receptor membranes and ionophore gating
US5874316A (en) * 1989-01-27 1999-02-23 Australian Membrane Biotechnology Research Institute Receptor membranes and ionophore gating
US5753258A (en) * 1990-10-19 1998-05-19 University Of Florida Artificial viral envelopes
US5252348A (en) * 1990-10-19 1993-10-12 Univ. Of Florida Research Foundation, Inc. Artificial viral envelopes
US5820879A (en) * 1993-02-12 1998-10-13 Access Pharmaceuticals, Inc. Method of delivering a lipid-coated condensed-phase microparticle composition
US5753261A (en) * 1993-02-12 1998-05-19 Access Pharmaceuticals, Inc. Lipid-coated condensed-phase microparticle composition
DE69527126T2 (de) * 1994-11-18 2002-12-12 Stichting Nl I Voor Zuivelonde Verfahren zur Kontrolle der Genexpression in Milchsäurebakterien
WO1999003889A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
US6165732A (en) * 1997-10-14 2000-12-26 Washington University Method for identifying apoptosis modulating compounds
GB9721901D0 (en) * 1997-10-16 1997-12-17 Univ Manchester Particles

Also Published As

Publication number Publication date
WO2003000233A3 (en) 2003-10-16
WO2003000233A2 (en) 2003-01-03
DK1397123T3 (da) 2010-05-03
EP1397123B1 (de) 2009-12-30
EP1397123A2 (de) 2004-03-17
EP1269993A1 (de) 2003-01-02
CA2451148A1 (en) 2003-01-03
ATE453380T1 (de) 2010-01-15
US20030118636A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
DE60234921D1 (de) Verabreichung von in lipidvesikeln verpackten kleinen hydrophilen molekülen
NO20001683L (no) Peptid/lipid-kompleksdannelse ved samlyofilisering
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
DE69937294D1 (de) Von cyclophilin b abstammende tumorantigen-peptide
CY2604B2 (en) Pharmaceutical preparations for drugs of low solubility
ATE273320T1 (de) Fusogene liposomen
NO933432L (no) Gassholdige kontrastmidler
DE69823055D1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
NO990276L (no) Ultralydavbildning av lever
DE69838147D1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
NO993257L (no) N-acylfosfatidyletanolaminformidlet liposomal legemiddelavlevering
ATE244015T1 (de) Formulierungen fuer faktor ix
ATE273025T1 (de) Dha-pharmazeutisches produkt konjugate
DE60126760D1 (de) Vektorkonstrukte
ATE322255T1 (de) Polyamid-oligomere
ATE301709T1 (de) Lipidabkömmlinge von pentaerythritol
DE60137835D1 (de) Modifizierte zytokine für krebs therapie
EP1364657A4 (de) Mittel gegen tumoren in hämatopoetischen organen
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
WO1996040627A3 (en) Thiocationic lipids, pharmaceutical compositions and methods of use thereof
ATE299704T1 (de) Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril
AU2002345433A1 (en) Delivery of small hydrophilic molecules packaged into lipid vesicles
TR199701225A2 (xx) Gen terapisi için katyonik lipidler.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition